US EditionTempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals - Tempus AI (NASDAQ:TEM)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals - Tempus AI (NASDAQ:TEM)
JP Morgan analyst Rachel Vatnsdal reiterated the Neutral rating on Tempus AI, Inc. (NASDAQ:TEM) on Wednesday, with a price forecast of $55. On Tuesday, Tempus AI reported first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The AI-focused precision medicine and patient care company reported a first-quarter adjusted loss of 24 cents per share, beating analyst estimates for a loss of 27 cents per share. The analyst notes…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
